RecruitingNCT07443826
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
PHASE1 · PHASE2 · 12 planned enrolment
- Countries listed
- 1
- Registry update
- July 13, 2026
immortal.lifePublic trial registrations naming Unlimited Biotechnology LLC as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE1 · PHASE2 · 12 planned enrolment